학술논문

The Rilutek((R)) (riluzole) Global Early Access Programme: An open-label safety evaluation in the treatment of amyotrophic lateral sclerosis
Document Type
Journal
Source
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS; SEP 2001, 2 3, p153-p158, 6p.
Subject
Language
English
ISSN
14660822